Outcome of metastatic colorectal cancer: Analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach

Diseases of the Colon and Rectum

Volumn 49, Issue 10, 2006, Pages 1596-1601

  Sperti, Elisa ^a   Faggiuolo, Roberto ^a   Gerbino, Alex ^a   Magnino, Antonella ^a   Muratore, Andrea ^a   Ortega, Cinzia ^a   Ferraris, Renato ^a   Leone, Francesco ^a   Capussotti, Lorenzo ^a   Aglietta, Massimo ^a  

^a CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

Integrated treatment; Metastatic colon cancer; Neoadjuvant chemotherapy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; FOLLOW UP; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; OUTCOME ASSESSMENT (HEALTH CARE); PALLIATIVE CARE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33751259641     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-006-0662-7     Document Type: Article

References (22)

1. JY Douillard D Cunningham AD Roth 2000 Irinotecan combined with Fluorouracil compared with Fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomised trial Lancet 355 1041 1047
2. LB Saltz JV Cox C Blanke 2000 Irinotecan plus Fluorouracil and Leucovorin for metastatic colorectal cancer. Irinotecan Study Group N Engl J Med 343 905 914
3. C Tournigand T Andre E Achille 2004 FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 229 237
4. RM Goldberg DJ Sargent RF Morton 2004 A randomized controlled trial of Fluorouracil plus Leucovorin, Irinotecan and Oxaliplatin combination in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 1 8
5. R Adam 2003 Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases Ann Oncol 14 13 16
6. G Fusai BR Davidson 2003 Management of colorectal liver metastases Colorectal Dis 5 2 23
7. B Nordlinger P Rougier 2002 Liver metastases from colorectal cancer: the turning point J Clin Oncol 20 1442 1445
8. WR Jarnagin Y Fong 1999 Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease J Am Coll Surg 188 33 42
9. B Nordlinger M Guiguet JC Vaillant 1996 Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie Cancer 77 1254 1262
10. Y Fong J Fortner RL Sun MF Brennan LH Blumgart 1999 Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 309 318
11. T Kato K Yasui T Hirai 2003 Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions Dis Colon Rectum 46 22 31
12. Y Fong J Salo 1999 Surgical therapy of hepatic colorectal metastasis Semin Oncol 26 514 523
13. R Adam E Avisar A Ariche 2001 Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal (liver) metastases Ann Surg Oncol 8 347 353
14. S Giacchetti M Itzhaki G Gruia 1999 Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, Leucovorin, Oxaliplatin and surgery Ann Oncol 10 663 669
15. C Pozzo M Basso A Cassano 2004 Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients Ann Oncol 15 933 939
16. A de Gramont A Figer M Seymour 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938 2947
17. H Bismuth R Adam F Levi 1996 Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy Ann Surg 224 509 522
18. S Giacchetti B Perpoint R Zidani 2000 Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer J Clin Oncol 18 136 147
19. R Adam V Delvart G Pascal 2004 Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 644 657
20. PJ Allen N Kemeny W Jarnagin R DeMatteo L Blumgart Y Fong 2003 Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases J Gastrointest Surg 7 109 117
21. D Cunningham Y Humblet S Siena 2004 Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 337 345
22. H Hurwitz L Fehrenbacher W Novotny 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 2342